4//SEC Filing
Pauls Matthew 4
Accession 0001753926-25-001884
CIK 0001919246other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 5:01 PM ET
Size
13.4 KB
Accession
0001753926-25-001884
Insider Transaction Report
Form 4
Pauls Matthew
Director
Transactions
- Exercise/Conversion
Common Stock
2025-07-02+8,493→ 8,493 total - Exercise/Conversion
Common Stock
2025-10-02+2,123→ 10,616 total - Gift
Common Stock
2025-12-10−9,542→ 1,074 total - Exercise/Conversion
Restricted Stock Units
2025-07-02−8,493→ 16,985 total→ Common Stock (8,493 underlying) - Exercise/Conversion
Restricted Stock Units
2025-10-02−2,123→ 14,862 total→ Common Stock (2,123 underlying)
Footnotes (3)
- [F1]As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units ("RSUs"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years.
- [F2]On December 10, 2025, the Reporting Person transferred 9,542 shares of Common Stock to GP 2024 Trust, U/A Dated, 12/20/2024, for no consideration. The Reporting Person is not a trustee and does not retain investment or voting control over the shares. Following the gift, the Reporting Person disclaims beneficial ownership of the shares held by the Trust and reports beneficial ownership herein only to the extent of any pecuniary interest, if any.
- [F3]Each RSU represents a contingent right to receive one share of issuer's Common Stock.
Documents
Issuer
Pelthos Therapeutics Inc.
CIK 0001919246
Entity typeother
Related Parties
1- filerCIK 0001573429
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 5:01 PM ET
- Size
- 13.4 KB